Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies.

about

Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies.

Item

http://www.wikidata.org/entity/Q42210837

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Mutational analysis of RNA spl ...... ren with myeloid malignancies.

@en

Mutational analysis of RNA spl ...... ren with myeloid malignancies.

@nl

type

Item

label

Mutational analysis of RNA spl ...... ren with myeloid malignancies.

@en

Mutational analysis of RNA spl ...... ren with myeloid malignancies.

@nl

prefLabel

Mutational analysis of RNA spl ...... ren with myeloid malignancies.

@en

Mutational analysis of RNA spl ...... ren with myeloid malignancies.

@nl

P1476

Mutational analysis of RNA spl ...... ren with myeloid malignancies.

@en

P2093

Andres Jerez

http://www.w3.org/2001/XMLSchema#string

Anna M Jankowska

http://www.w3.org/2001/XMLSchema#string

Hideki Makishima

http://www.w3.org/2001/XMLSchema#string

Hideki Muramatsu

http://www.w3.org/2001/XMLSchema#string

Hirotoshi Sakaguchi

http://www.w3.org/2001/XMLSchema#string

Jaroslaw P Maciejewski

http://www.w3.org/2001/XMLSchema#string

Ramon V Tiu

http://www.w3.org/2001/XMLSchema#string

Seiji Kojima

http://www.w3.org/2001/XMLSchema#string

Valeria Visconte

http://www.w3.org/2001/XMLSchema#string

P2860

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

Frequent pathway mutations of splicing machinery in myelodysplasia

Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia.

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis

Mutations in CBL occur frequently in juvenile myelomonocytic leukemia.

Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia.

Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia.

Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.

P304

e215-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.LEUKRES.2012.06.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22748922

http://www.w3.org/2001/XMLSchema#string

P921

RNA analysis

P932

4535703

http://www.w3.org/2001/XMLSchema#string